These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 8271122

  • 1. Interleukin-2 production in pediatric inflammatory bowel disease: evidence for dissimilar mononuclear cell function in Crohn's disease and ulcerative colitis.
    Gurbindo C, Sabbah S, Menezes J, Justinich C, Marchand R, Seidman EG.
    J Pediatr Gastroenterol Nutr; 1993 Oct; 17(3):247-54. PubMed ID: 8271122
    [Abstract] [Full Text] [Related]

  • 2. Crohn's disease, ulcerative colitis, and normal intestinal lymphocytes express integrins in dissimilar patterns.
    Yacyshyn BR, Lazarovits A, Tsai V, Matejko K.
    Gastroenterology; 1994 Nov; 107(5):1364-71. PubMed ID: 7523224
    [Abstract] [Full Text] [Related]

  • 3. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.
    Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, Raedler A.
    Clin Exp Immunol; 1993 Oct; 94(1):174-81. PubMed ID: 8403503
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Increased expression of interleukin-12 receptor beta(2) on lamina propria mononuclear cells of patients with active Crohn's disease.
    Stallmach A, Marth T, Adrian N, Wittig BM, Ecker KW, Schilling M, Zeitz M.
    Int J Colorectal Dis; 2002 Sep; 17(5):303-10. PubMed ID: 12172923
    [Abstract] [Full Text] [Related]

  • 8. Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease.
    Mitsialis V, Wall S, Liu P, Ordovas-Montanes J, Parmet T, Vukovic M, Spencer D, Field M, McCourt C, Toothaker J, Bousvaros A, Boston Children’s Hospital Inflammatory Bowel Disease Center, Brigham and Women’s Hospital Crohn’s and Colitis Center, Shalek AK, Kean L, Horwitz B, Goldsmith J, Tseng G, Snapper SB, Konnikova L.
    Gastroenterology; 2020 Aug; 159(2):591-608.e10. PubMed ID: 32428507
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Crossover Subsets of CD4+ T Lymphocytes in the Intestinal Lamina Propria of Patients with Crohn's Disease and Ulcerative Colitis.
    Li J, Ueno A, Iacucci M, Fort Gasia M, Jijon HB, Panaccione R, Kaplan GG, Beck PL, Luider J, Barkema HW, Qian J, Gui X, Ghosh S.
    Dig Dis Sci; 2017 Sep; 62(9):2357-2368. PubMed ID: 28573508
    [Abstract] [Full Text] [Related]

  • 11. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
    Bisping G, Lügering N, Lütke-Brintrup S, Pauels HG, Schürmann G, Domschke W, Kucharzik T.
    Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-17 immunity in pediatric Crohn disease and ulcerative colitis.
    Hölttä V, Klemetti P, Salo HM, Koivusalo A, Pakarinen M, Westerholm-Ormio M, Kolho KL, Vaarala O.
    J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):287-92. PubMed ID: 23974060
    [Abstract] [Full Text] [Related]

  • 13. Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease.
    Ludwiczek O, Vannier E, Borggraefe I, Kaser A, Siegmund B, Dinarello CA, Tilg H.
    Clin Exp Immunol; 2004 Nov; 138(2):323-9. PubMed ID: 15498044
    [Abstract] [Full Text] [Related]

  • 14. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
    Beltrán CJ, Candia E, Erranz B, Figueroa C, Gonzalez MJ, Quera R, Hermoso MA.
    Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls.
    Kusugami K, Youngman KR, West GA, Fiocchi C.
    Gastroenterology; 1989 Jul; 97(1):1-9. PubMed ID: 2785943
    [Abstract] [Full Text] [Related]

  • 17. Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease.
    Schreiber S, MacDermott RP, Raedler A, Pinnau R, Bertovich MJ, Nash GS.
    Gastroenterology; 1991 Oct; 101(4):1020-30. PubMed ID: 1889695
    [Abstract] [Full Text] [Related]

  • 18. Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis.
    Mullin GE, Lazenby AJ, Harris ML, Bayless TM, James SP.
    Gastroenterology; 1992 May; 102(5):1620-7. PubMed ID: 1568572
    [Abstract] [Full Text] [Related]

  • 19. Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease.
    Fiocchi C, Hilfiker ML, Youngman KR, Doerder NC, Finke JH.
    Gastroenterology; 1984 Apr; 86(4):734-42. PubMed ID: 6607860
    [Abstract] [Full Text] [Related]

  • 20. Increased expression of interleukin 17 in inflammatory bowel disease.
    Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, Bamba T, Fujiyama Y.
    Gut; 2003 Jan; 52(1):65-70. PubMed ID: 12477762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.